|
|
|
Volumn 37, Issue 2, 1985, Pages 217-227
|
|
Bromocriptine in Parkinson disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;
AMANTADINE;
AMPHETAMINE;
BENSERAZIDE;
BENSERAZIDE PLUS LEVODOPA;
BROMOCRIPTINE;
CARBIDOPA;
CARBIDOPA PLUS LEVODOPA;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
ERGOLINE DERIVATIVE;
IBOTENIC ACID;
KAINIC ACID;
LERGOTRILE;
LEVODOPA;
LISURIDE;
MESULERGINE;
METIROSINE;
OXIDOPAMINE;
PERGOLIDE;
ADVERSE DRUG REACTION;
CARDIOVASCULAR SYSTEM;
CENTRAL NERVOUS SYSTEM;
DIGESTIVE SYSTEM;
DOPAMINE H 3;
DRUG COMPARISON;
DRUG DOSE;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG THERAPY;
DYSKINESIA;
GASTROINTESTINAL SYMPTOM;
GASTROINTESTINAL TOXICITY;
HALOPERIDOL H 3;
HUMAN;
INTOXICATION;
MENTAL DISEASE;
NERVOUS SYSTEM;
NEUROTOXICITY;
ORTHOSTATIC HYPOTENSION;
PARKINSON DISEASE;
PHARMACOLOGY;
PRIORITY JOURNAL;
REVIEW;
SPIPERONE H 3;
THERAPY;
AGED;
ANIMAL;
BROMOCRIPTINE;
DRUG ADMINISTRATION SCHEDULE;
ERGOLINES;
HUMAN;
LEVODOPA;
LISURIDE;
MIDDLE AGE;
PARKINSON DISEASE;
PERGOLIDE;
TIME FACTORS;
|
|
EID: 0022185368
PISSN: 00316997
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (71)
|
|
References (0)
|